Wells Fargo & Company Tekla Life Sciences Investors Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Wells Fargo & Company holds 2,395 shares of HQL stock, worth $35,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,395
Previous 1,014 136.19%
Holding current value
$35,230
Previous $13,000 153.85%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$12.79 - $14.27 $17,662 - $19,706
1,381 Added 136.19%
2,395 $33,000
Q1 2024

May 10, 2024
BUY
$13.38 - $14.33 $2,060 - $2,206
154 Added 17.91%
1,014 $13,000
Q4 2023

Feb 09, 2024
SELL
$11.35 - $13.6 $100,731 - $120,700
-8,875 Reduced 91.17%
860 $11,000
Q3 2023

Nov 13, 2023
SELL
$12.38 - $13.69 $1.18 Million - $1.31 Million
-95,703 Reduced 90.77%
9,735 $121,000
Q2 2023

Aug 15, 2023
SELL
$13.13 - $14.17 $257,886 - $278,312
-19,641 Reduced 15.7%
105,438 $1.43 Million
Q1 2023

May 12, 2023
SELL
$13.37 - $14.94 $2.12 Million - $2.37 Million
-158,468 Reduced 55.89%
125,079 $1.74 Million
Q4 2022

Feb 13, 2023
SELL
$13.55 - $15.23 $744,342 - $836,629
-54,933 Reduced 16.23%
283,547 $4.03 Million
Q3 2022

Nov 14, 2022
BUY
$13.39 - $16.31 $605,147 - $737,114
45,194 Added 15.41%
338,480 $4.62 Million
Q2 2022

Aug 12, 2022
BUY
$13.11 - $17.02 $160,230 - $208,018
12,222 Added 4.35%
293,286 $4.17 Million
Q1 2022

May 16, 2022
SELL
$15.35 - $19.29 $327,001 - $410,934
-21,303 Reduced 7.05%
281,064 $4.65 Million
Q4 2021

Feb 14, 2022
SELL
$18.5 - $21.59 $763,587 - $891,127
-41,275 Reduced 12.01%
302,367 $5.82 Million
Q3 2021

Nov 15, 2021
BUY
$20.27 - $22.67 $337,819 - $377,818
16,666 Added 5.1%
343,642 $7.15 Million
Q2 2021

Aug 16, 2021
SELL
$19.14 - $21.44 $1.49 Million - $1.67 Million
-77,818 Reduced 19.22%
326,976 $7.01 Million
Q1 2021

May 13, 2021
SELL
$19.31 - $22.07 $669,574 - $765,277
-34,675 Reduced 7.89%
404,794 $7.98 Million
Q4 2020

Feb 09, 2021
BUY
$16.8 - $20.21 $2.58 Million - $3.11 Million
153,643 Added 53.75%
439,469 $8.68 Million
Q3 2020

Nov 05, 2020
BUY
$16.71 - $19.06 $679,411 - $774,960
40,659 Added 16.58%
285,826 $5.03 Million
Q2 2020

Aug 13, 2020
SELL
$14.22 - $18.38 $142,043 - $183,597
-9,989 Reduced 3.91%
245,167 $4.4 Million
Q1 2020

May 14, 2020
BUY
$12.22 - $17.99 $3.12 Million - $4.59 Million
255,156 New
255,156 $3.82 Million

Others Institutions Holding HQL

# of Institutions
80
Shares Held
9.03M
Call Options Held
0
Put Options Held
0
View Full List

About TEKLA LIFE SCIENCES INVESTORS

HQL Quotes by TradingView
  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email